BridgeMD
New treatment option for Parkinson Disease
Official title Evaluation of the Effects of Aquatic Therapy on Activities of Daily Living, Walking, Balance, Posture, Pain, and Depression in Parkinson's Patients
ClinicalTrials.gov ID: NCT07390825
What this study is testing
- What it's testing
- Parkinson's Disease (PD) is a progressive neurodegenerative disorder characterized by motor symptoms such as bradykinesia, tremors, and postural instability, as well as various non-motor symptoms. Conventional land-based rehabilitation is standard; however, aquatherapy-utilizing water's buoyancy, hydrostatic pressure, and viscosity-offers a promising alternative to improve balance and mobility while reducing fall risks.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 40 to 80
You may be able to join if
- Having a diagnosis of Idiopathic Parkinson's Disease between the ages of 40-80 and consenting to the treatment.
- Being regularly followed by a neurologist and having a stable medical treatment regimen for at least 3 months.
- Having a disease stage between 1-3 according to the Modified Hoehn-Yahr Staging Scale (MHY).
- A score of 24 or higher on the Mini-Mental State Examination (MMSE).
- Being able to verticalize independently and ambulate with or without assistance.
You likely can't join if
- Having orthopedic, rheumatological, or non-Parkinson's neurological disorders that affect functional status.
- Having a medical treatment regimen that has been modified within the last 3 months.
- Presence of Atypical Parkinson's Disease.
- Visual impairment.
- Presence of dementia.
- Decompensated cardiac or respiratory failure.
See the full eligibility criteria
- Having a diagnosis of Idiopathic Parkinson's Disease between the ages of 40-80 and consenting to the treatment.
- Being regularly followed by a neurologist and having a stable medical treatment regimen for at least 3 months.
- Having a disease stage between 1-3 according to the Modified Hoehn-Yahr Staging Scale (MHY).
- A score of 24 or higher on the Mini-Mental State Examination (MMSE).
- Being able to verticalize independently and ambulate with or without assistance.
- Having orthopedic, rheumatological, or non-Parkinson's neurological disorders that affect functional status.
- Having a medical treatment regimen that has been modified within the last 3 months.
- Presence of Atypical Parkinson's Disease.
- Visual impairment.
- Presence of dementia.
- Decompensated cardiac or respiratory failure.
- Diabetes insipidus.
- Presence of systemic infection.
- Impaired skin integrity or the presence of skin infections.
- Increased sensitivity to inhaled steam or water chemicals.
- History of epilepsy or asthma.
- Urinary or fecal incontinence.
- Refusal to participate in or consent to the treatment.
The study team makes the final eligibility decision.
Where it's taking place
- Çankaya, Ankara, Turkey (Türkiye)
- Ankara, ÇANKAYA, Turkey (Türkiye)
Compensation & support
A stipend or compensation may be offered.
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 40 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Çankaya, Ankara, Turkey (Türkiye); Ankara, ÇANKAYA, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.